China data
The interaction of macro and markets. The October data was rightfully categorised as “awful”.
The rescue packages to property are reflective of this, as they are of the COVID-0 impact. But the support drives the forward looking market, which has rallied hard this past month.
State champions (e.g. across tech/services) also enjoying support (read as “less crackdown-interference-usurping-profit-for-state-cause”) driving a beaten down market further still. But at least 2/3rds of this approach can’t work, longer run.
The iron laws of economics are not so brittle, and you can’t keep up a market that “needs”, (and even wants) to collapse, e.g. property due to over-investment, and you can’t lighten your approach to a virus when you haven’t vaccinated. There is no “trade-off” x vaccines.
That leaves tech. No reason that can’t have a run if they keep more profits to/for themselves, as opposed to being captured by the state or staff.
No specific call to action here. We view EM as a trading exposure, around a very modest SAA weight.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.